Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole in GH Deficient Adolescent Males
NCT00133354Phase 3Completed
- Sponsor
- Nemours Children's Health
- Start
- Nov 2001
- Primary completion
- Aug 2006
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in growth hormone deficiency (GHD) comparing Anastrozole + GH with Placebo + GH (2 arms). Primary endpoint: Change in predicted adult height based on rate of bone age advancement at 36 months. Started Nov 2001; status: completed.
02
Drugs
anastrozole
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00133354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133354.